Trump’s upcoming tariffs have the potential to bring biopharma manufacturing to the US, which could impact companies with overseas production.
Jefferies managing director Michael Yee joins Market Domination Overtime to discuss how tariffs could impact the biotech sector. He emphasizes Vertex (VRTX), Amgen (AMGN), and Gilead (GILD) as some of his top large-cap picks in the sector.
To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here: https://finance.yahoo.com/videos/series/market-domination-overtime/
#youtube #stocks #medicine
About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
– Get the latest news and data at finance.yahoo.com
– Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)
– Follow Yahoo Finance on social:
X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/company/yahoo-finance
